Clinical Trials in Colorado

Showing 6841-6860 of 13,761 trials

Feasibility of Telemedicine Medical Abortion

NCT04599725

This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.

Pregnancy

Gynuity Health Projects413 participantsStarted Oct 2020

Denver, Colorado, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +12 more locations

COMPLETEDPhase 1/250 miles

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

NCT01496118

Relapsed/refractory Multiple Myeloma (MM) is an incurable disorder with a poor prognosis. Carfilzomib is a novel proteasome inhibitor with activity in this setting. Panobinostat is a pan-deacetylase inhibitor which has shown synergistic cytotoxicity in vitro and in vivo with proteasome inhibitors. The combination should enhance the activity of both agents against myeloma cells. In Phase I, the optimal doses of the combination of carfilzomib and panobinostat will be determined. Assuming this combination is feasible, the Phase II portion will proceed using the doses determined in Phase I.

Multiple Myeloma

SCRI Development Innovations, LLC80 participantsStarted Dec 2011

Denver, Colorado, United States • Fort Myers, Florida, United States • Pensacola, Florida, United States +10 more locations

Feasibility of Telemedicine Medical Abortion

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

Find Trials by Condition in Colorado

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

A Multi-Center Trial to Study Acute Liver Failure in Adults

A Phase 2 Study of CIM331 for Atopic Dermatitis Patients

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors